$0.8800
-0.06-6.38%
At close: -
$0.8500
-0.03-3.41%
After Hours: Jan 17, 7:59 PM EDT
Comments
Loading...
Silexion Therapeutics (NASDAQ:SLXN) Stock, Earnings Estimates, EPS, And Revenue
Silexion Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 14
EPS
$-18.270
Quarterly Revenue
$0.00
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Silexion Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Silexion Therapeutics (SLXN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Silexion Therapeutics (SLXN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Silexion Therapeutics (NASDAQ:SLXN) reporting earnings?
Silexion Therapeutics (SLXN) is scheduled to report earnings on February 21, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for Silexion Therapeutics (NASDAQ:SLXN)?
The Actual EPS was $-18.27, which missed the estimate of $0.00.
What were Silexion Therapeutics’s (NASDAQ:SLXN) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.